                         SEQUENCE LISTING

<110>  BERKELEY LIGHTS, INC.
 
<120>  Proto-Antigen-Presenting Synthetic Surfaces,  
       Activated T Cells, and Uses Thereof

<130>  01149-0016-00PCT

<150>  US 62/747,569
<151>  2018-10-18

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Exemplary initial peptide sequence

<400>  1

Gly Met Gly Gln Lys Asp Ser Tyr Val 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Exemplary initial peptide sequence

<400>  2

Arg Met Gln Lys Glu Ile Thr Ala Leu 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Exemplary initial peptide sequence

<400>  3

Gln Leu Ala Lys Leu Met Ala Thr Leu 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Exemplary initial peptide sequence

<400>  4

Leu Met Tyr Ala Lys Arg Ala Phe Val 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  SLC45A2-derived peptide

<400>  5

Ser Leu Tyr Ser Tyr Phe Gln Lys Val 
1               5                   


<210>  6
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  TCL1-derived peptide

<400>  6

Ser Leu Leu Pro Ile Met Trp Gln Leu Tyr 
1               5                   10  


<210>  7
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  MART1 tumor associated antigen

<400>  7

Glu Leu Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  8
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  NYESO1 tumor associated antigen

<400>  8

Ser Leu Leu Met Trp Ile Thr Gln Val 
1               5                   


